Previous close | 0.1000 |
Open | 0.1000 |
Bid | 0.0000 |
Ask | 0.1500 |
Strike | 44.00 |
Expiry date | 2024-10-11 |
Day's range | 0.1000 - 0.1000 |
Contract range | N/A |
Volume | |
Open interest | 82 |
CPB has shown resilience through its strategic execution and focus on innovation while facing challenges related to a volatile consumer environment.
Lower inflation means less top-line growth from price hikes, and sales volume is under pressure as consumers are more selective.
Investing.com -- As signs emerge that demand for GLP-1 drugs is stronger than expected, many are fearing the worst for packaged-food companies, but Bernstein believes that some companies are likely to fare better than others as patients on these weight-loss drugs shift appetite in favor of more protein-based foods.